Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment
European Journal of Pharmaceutical Sciences · 2023
DOI: 10.1016/j.ejps.2023.106591 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2023. Verfasst von Daisuke Kurimoto und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo 192-0982, Japan. Hauptthemen laut MEDLINE: Albumins, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tokyo University of Technology.
Abstract (Originalsprache)
Albumin fusion or conjugation is a well-established technique for tumor delivery and is mainly mediated by albumin-induced caveolae-dependent endocytosis. We report that caveolae-dependent endocytic signaling activated by human serum albumin (HSA) is not sufficiently strong to induce cellular uptake, mainly due to its electrostatic repulsion from the negatively charged cell surface sulfated glycosaminoglycans (GAGs), and fusion of the cell-surface-retained protein with HSA is an effective strategy to activate the HSA-induced endocytic signal, thereby improving its intracellular uptake. In this study, human lactoferrin (hLF), a protein that accumulates on the cell surface along with GAGs, was selected for delivery into human lung adenocarcinoma PC-14 cells. When added exogenously, hLF-fused HSA (hLF-HSA) was successfully endocytosed, whereas the simultaneous addition of HSA and hLF did not result in endocytosis, indicating less efficient activation of endocytic signaling by HSA alone and the importance of its fusion. Importantly, the treatment of cells with chlorate, a known inhibitor of GAG sulfation, dramatically suppressed the endocytosis of hLF-HSA owing to the loss of the hLF-GAG interaction. Therefore, the cell-surface localization of HSA imposed by fusion with the cell-surface-retained protein enhances its binding to the relevant receptor, which improves intracellular delivery as an albumin-fusion platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo 192-0982, Japan.
- School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo 192-0982, Japan. Electronic address: atsato@stf.teu.ac.jp.
Förderung
- Tokyo University of Technology
Zitieren
APA
Kurimoto, D., & Sato, A. (2023). Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2023.106591
Vancouver
Kurimoto D, Sato A. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment. European Journal of Pharmaceutical Sciences. 2023. doi:10.1016/j.ejps.2023.106591
BibTeX
@article{Kurimoto2023,
author = {Kurimoto, Daisuke and Sato, Atsushi},
title = {Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment},
journal = {European Journal of Pharmaceutical Sciences},
year = {2023},
doi = {10.1016/j.ejps.2023.106591}
}
EUVIMED